IRCT20110603006699N5招募中2 期
Comparison and evaluation of the effect of rivaroxaban in the complementary treatment of sudden sensorineural hearing loss
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 入组人数
- 34
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 no limit（—）
- 性别
- All
入选标准
- •Diagnosis of SNHL by an ENT specialist
- •Reduction of more than 30 dB in hearing at least 3 frequencies
- •Body mass index between 18-30 kg per square meter
- •Negative pregnancy test in women of reproductive age 15-35 years
- •Normal coagulation tests
- •Normal renal function
- •Regular visits for follow up
- •Consent to enter the study
排除标准
- •Previous hemorrhagic diseases such as intracranial hemorrhage
- •Previous coagulation diseases
- •History of previous thrombosis anywhere on the body
- •Active stomach ulcers
- •History of psychiatric diseases
- •Any previous illness or surgery on the ears
- •Any signs of inflammation or infection of the ear on examination
- •History of hearing loss
- •Meniere's disease
- •Recent vocal or compressive trauma
- •Underlying disease that may be the cause of SNHL, such as trauma, autotoxic drugs, infection, etc
- •Blood pressure higher than 180/110
- •Uncontrolled diabetes
- •Hypersensitivity reaction to corticosteroids
- •Taking drugs such as methadone
研究者
相似试验
尚未招募
2 期
The effect of rivaroxaban and enoxaparin on the prophylaxis of venous thromboembolismIRCT20161121031003N4Iran University of Medical Sciences150
招募中
3 期
Rivaroxaban, heparin and enoxaparin as thromboprophylaxis agents for gynecology oncologic surgeryPulmonary embolismIRCT20151020024625N19Semnan University of Medical Sciences90
招募中
2 期
Efficiency of rivaroxaban and enoxaparin in the prevention of venous thromboembolic eventsSpinal fusion.Osseous stenosis of neural canalM99.3IRCT20120527009878N16Tabriz University of Medical Sciences60
进行中（未招募）
1 期
Effects on human body of Rivaroxaban in patients with coronary artery disease and atrial fibrillation.stable CADhistory of atrial fibrillationMedDRA version: 20.0Level: PTClassification code 10003658Term: Atrial fibrillationSystem Organ Class: 10007541 - Cardiac disordersMedDRA version: 20.0Level: LLTClassification code 10021279Term: IHDSystem Organ Class: 10007541 - Cardiac disordersEUCTR2020-005110-17-ITAZIENDA OSPEDALIERO UNIVERSITARIA MAGGIORE DELLA CARITà DI NOVARA45
招募中
3 期
Efficacy and safety of rivaroxaban and subcutaneous enoxaparin after spinal surgeryIntravenous thromboembolism.Thromboembolism in the puerperiumO88.23IRCT20211109053014N1Esfahan University of Medical Sciences200